Comera Life Sciences Announces Collaboration With Quality Chemical Laboratories To Secure Proprietary Supply Of SQore Excipients
Portfolio Pulse from Happy Mohamed
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) has announced a partnership with Quality Chemical Laboratories, Inc. (QCL) to manufacture one of Comera's lead SQore™ excipients. This is part of a broader strategy to secure the GMP manufacturing and supply chain of key proprietary technology owned by the Company. Comera's SQore platform is used to transform intravenously administered biologics into patient delivered subcutaneous formulations.
July 20, 2023 | 12:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Comera's partnership with QCL to manufacture SQore excipients is a strategic move to secure the supply chain of its proprietary technology. This could potentially enhance Comera's product development capabilities and market position.
The partnership with QCL allows Comera to have full control over the supply chain of its SQore excipients, which are key to its product development. This could potentially lead to greater flexibility and efficiency in product development, and enhance Comera's competitive advantage in the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100